不同同种异体处理方案骨-髌腱-骨异体移植重建前交叉韧带的比较结果。

IF 2.4 3区 医学 Q2 ORTHOPEDICS
Orthopaedic Journal of Sports Medicine Pub Date : 2025-06-19 eCollection Date: 2025-06-01 DOI:10.1177/23259671251345676
Benjamin Miltenberg, Randall Timothy Kreulen, Gaston Davis, William L Johns, Rahul Muchintala, Jonathan Berg, Fotios P Tjoumakaris, Kevin B Freedman
{"title":"不同同种异体处理方案骨-髌腱-骨异体移植重建前交叉韧带的比较结果。","authors":"Benjamin Miltenberg, Randall Timothy Kreulen, Gaston Davis, William L Johns, Rahul Muchintala, Jonathan Berg, Fotios P Tjoumakaris, Kevin B Freedman","doi":"10.1177/23259671251345676","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Graft choice in anterior cruciate ligament reconstruction (ACLR) is determined by surgeon preference, patient factors, and graft characteristics. An allograft is a viable option with benefits such as decreased operative times and no donor site morbidities, and it can be the preferred graft choice in certain patient populations. Despite this, there is no established standard for allograft processing.</p><p><strong>Purpose: </strong>To determine whether allograft processing techniques influence the risk of graft failure, patient-reported outcomes, and revision surgery in patients undergoing ACLR.</p><p><strong>Study design: </strong>Cohort study; Level of evidence, 3.</p><p><strong>Methods: </strong>Consecutive patients from 3 fellowship-trained sports medicine surgeons undergoing ACLR with patellar tendon allografts from January 1, 2016, to January 1, 2022, were identified. Descriptive data, mechanism of injury, graft processing technique, revision history, and patient-reported outcome scores were collected. The primary endpoint was aseptic failure as defined by graft rupture on magnetic resonance imaging. Statistical analysis was performed with the χ<sup>2</sup> test or the Fisher exact test as indicated for categorical variables and with the <i>t</i> test and analysis of variance as indicated for continuous variables. The significance level for statistical tests was set at 5%.</p><p><strong>Results: </strong>A total of 189 patients who underwent ACLR and met the inclusion/exclusion criteria were identified, with 103 Musculoskeletal Transplant Foundation (MTF), 55 Allowash XG, and 31 BioCleanse allografts. The mean age of patients was 43.4 ± 10.5 years, and 60.9% were women. No significant difference was observed between the groups with regard to sex and body mass index (<i>P</i> = .25 and <i>P</i> = .64, respectively). However, age at the time of surgery was significantly different between groups (<i>P</i> = .03). The mean patient follow-up time was 4.65 ± 1.40 years. Four patients experienced graft failure (MTF 1% [1/103]; Allowash XG 5.5% [3/55]; BioCleanse 0% [0/31]), with no significant difference in graft failure between groups (<i>P</i> = .20). There were no reported infections. Postoperative International Knee Documentation Committee (IKDC) scores (MTF, 82.6; Allowash XG, 81.7; BioCleanse, 80.2) were not different between groups (<i>P</i> = .60).</p><p><strong>Conclusion: </strong>Bone-patellar tendon-bone allografts processed using BioCleanse, Allowash XG, and the MTF protocol had similar rates of graft failure and postoperative IKDC scores. Although underpowered, the data suggest that each of these techniques can be used safely with low failure rates and good functional outcomes.</p>","PeriodicalId":19646,"journal":{"name":"Orthopaedic Journal of Sports Medicine","volume":"13 6","pages":"23259671251345676"},"PeriodicalIF":2.4000,"publicationDate":"2025-06-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12179472/pdf/","citationCount":"0","resultStr":"{\"title\":\"Comparative Outcomes After Bone-Patellar Tendon-Bone Allograft Reconstruction of the Anterior Cruciate Ligament Using Various Allograft Processing Protocols.\",\"authors\":\"Benjamin Miltenberg, Randall Timothy Kreulen, Gaston Davis, William L Johns, Rahul Muchintala, Jonathan Berg, Fotios P Tjoumakaris, Kevin B Freedman\",\"doi\":\"10.1177/23259671251345676\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Graft choice in anterior cruciate ligament reconstruction (ACLR) is determined by surgeon preference, patient factors, and graft characteristics. An allograft is a viable option with benefits such as decreased operative times and no donor site morbidities, and it can be the preferred graft choice in certain patient populations. Despite this, there is no established standard for allograft processing.</p><p><strong>Purpose: </strong>To determine whether allograft processing techniques influence the risk of graft failure, patient-reported outcomes, and revision surgery in patients undergoing ACLR.</p><p><strong>Study design: </strong>Cohort study; Level of evidence, 3.</p><p><strong>Methods: </strong>Consecutive patients from 3 fellowship-trained sports medicine surgeons undergoing ACLR with patellar tendon allografts from January 1, 2016, to January 1, 2022, were identified. Descriptive data, mechanism of injury, graft processing technique, revision history, and patient-reported outcome scores were collected. The primary endpoint was aseptic failure as defined by graft rupture on magnetic resonance imaging. Statistical analysis was performed with the χ<sup>2</sup> test or the Fisher exact test as indicated for categorical variables and with the <i>t</i> test and analysis of variance as indicated for continuous variables. The significance level for statistical tests was set at 5%.</p><p><strong>Results: </strong>A total of 189 patients who underwent ACLR and met the inclusion/exclusion criteria were identified, with 103 Musculoskeletal Transplant Foundation (MTF), 55 Allowash XG, and 31 BioCleanse allografts. The mean age of patients was 43.4 ± 10.5 years, and 60.9% were women. No significant difference was observed between the groups with regard to sex and body mass index (<i>P</i> = .25 and <i>P</i> = .64, respectively). However, age at the time of surgery was significantly different between groups (<i>P</i> = .03). The mean patient follow-up time was 4.65 ± 1.40 years. Four patients experienced graft failure (MTF 1% [1/103]; Allowash XG 5.5% [3/55]; BioCleanse 0% [0/31]), with no significant difference in graft failure between groups (<i>P</i> = .20). There were no reported infections. Postoperative International Knee Documentation Committee (IKDC) scores (MTF, 82.6; Allowash XG, 81.7; BioCleanse, 80.2) were not different between groups (<i>P</i> = .60).</p><p><strong>Conclusion: </strong>Bone-patellar tendon-bone allografts processed using BioCleanse, Allowash XG, and the MTF protocol had similar rates of graft failure and postoperative IKDC scores. Although underpowered, the data suggest that each of these techniques can be used safely with low failure rates and good functional outcomes.</p>\",\"PeriodicalId\":19646,\"journal\":{\"name\":\"Orthopaedic Journal of Sports Medicine\",\"volume\":\"13 6\",\"pages\":\"23259671251345676\"},\"PeriodicalIF\":2.4000,\"publicationDate\":\"2025-06-19\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12179472/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Orthopaedic Journal of Sports Medicine\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1177/23259671251345676\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/6/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q2\",\"JCRName\":\"ORTHOPEDICS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Orthopaedic Journal of Sports Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/23259671251345676","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/6/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"ORTHOPEDICS","Score":null,"Total":0}
引用次数: 0

摘要

背景:前交叉韧带重建(ACLR)的移植物选择取决于外科医生的偏好、患者因素和移植物的特点。同种异体移植物是一种可行的选择,具有减少手术时间和无供体部位并发症等优点,可以成为某些患者群体的首选移植物。尽管如此,对于同种异体移植的处理还没有确定的标准。目的:确定同种异体移植物处理技术是否影响ACLR患者移植物失败的风险、患者报告的结果和翻修手术。研究设计:队列研究;证据水平,3。方法:选取2016年1月1日至2022年1月1日期间连续接受同种异体髌骨肌腱ACLR移植的3名运动医学外科医生的患者。收集描述性数据、损伤机制、移植物处理技术、翻修史和患者报告的结果评分。主要终点是无菌失败,通过磁共振成像确定移植物破裂。对分类变量采用χ2检验或Fisher精确检验,对连续变量采用t检验和方差分析进行统计分析。统计学检验的显著性水平设为5%。结果:共有189例患者接受了ACLR并符合纳入/排除标准,其中103例为肌肉骨骼移植基金会(MTF), 55例为Allowash XG, 31例为BioCleanse同种异体移植物。患者平均年龄43.4±10.5岁,女性占60.9%。在性别和体重指数方面,各组之间没有显著差异(P = 0.25和P = 0.64)。但两组患者手术时年龄差异有统计学意义(P = 0.03)。患者平均随访时间为4.65±1.40年。4例患者发生移植物衰竭(MTF 1% [1/103];许值XG 5.5% [3/55];bioclean0%[0/31]),两组间移植物衰竭无显著差异(P = .20)。没有感染报告。术后国际膝关节文献委员会(IKDC)评分(MTF, 82.6;允许XG, 81.7;BioCleanse, 80.2)组间差异无统计学意义(P = 0.60)。结论:使用BioCleanse、Allowash XG和MTF方案处理的骨-髌骨肌腱-骨同种异体移植物具有相似的移植物失败率和术后IKDC评分。虽然动力不足,但数据表明,每种技术都可以安全使用,故障率低,功能预后良好。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Comparative Outcomes After Bone-Patellar Tendon-Bone Allograft Reconstruction of the Anterior Cruciate Ligament Using Various Allograft Processing Protocols.

Background: Graft choice in anterior cruciate ligament reconstruction (ACLR) is determined by surgeon preference, patient factors, and graft characteristics. An allograft is a viable option with benefits such as decreased operative times and no donor site morbidities, and it can be the preferred graft choice in certain patient populations. Despite this, there is no established standard for allograft processing.

Purpose: To determine whether allograft processing techniques influence the risk of graft failure, patient-reported outcomes, and revision surgery in patients undergoing ACLR.

Study design: Cohort study; Level of evidence, 3.

Methods: Consecutive patients from 3 fellowship-trained sports medicine surgeons undergoing ACLR with patellar tendon allografts from January 1, 2016, to January 1, 2022, were identified. Descriptive data, mechanism of injury, graft processing technique, revision history, and patient-reported outcome scores were collected. The primary endpoint was aseptic failure as defined by graft rupture on magnetic resonance imaging. Statistical analysis was performed with the χ2 test or the Fisher exact test as indicated for categorical variables and with the t test and analysis of variance as indicated for continuous variables. The significance level for statistical tests was set at 5%.

Results: A total of 189 patients who underwent ACLR and met the inclusion/exclusion criteria were identified, with 103 Musculoskeletal Transplant Foundation (MTF), 55 Allowash XG, and 31 BioCleanse allografts. The mean age of patients was 43.4 ± 10.5 years, and 60.9% were women. No significant difference was observed between the groups with regard to sex and body mass index (P = .25 and P = .64, respectively). However, age at the time of surgery was significantly different between groups (P = .03). The mean patient follow-up time was 4.65 ± 1.40 years. Four patients experienced graft failure (MTF 1% [1/103]; Allowash XG 5.5% [3/55]; BioCleanse 0% [0/31]), with no significant difference in graft failure between groups (P = .20). There were no reported infections. Postoperative International Knee Documentation Committee (IKDC) scores (MTF, 82.6; Allowash XG, 81.7; BioCleanse, 80.2) were not different between groups (P = .60).

Conclusion: Bone-patellar tendon-bone allografts processed using BioCleanse, Allowash XG, and the MTF protocol had similar rates of graft failure and postoperative IKDC scores. Although underpowered, the data suggest that each of these techniques can be used safely with low failure rates and good functional outcomes.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Orthopaedic Journal of Sports Medicine
Orthopaedic Journal of Sports Medicine Medicine-Orthopedics and Sports Medicine
CiteScore
4.30
自引率
7.70%
发文量
876
审稿时长
12 weeks
期刊介绍: The Orthopaedic Journal of Sports Medicine (OJSM), developed by the American Orthopaedic Society for Sports Medicine (AOSSM), is a global, peer-reviewed, open access journal that combines the interests of researchers and clinical practitioners across orthopaedic sports medicine, arthroscopy, and knee arthroplasty. Topics include original research in the areas of: -Orthopaedic Sports Medicine, including surgical and nonsurgical treatment of orthopaedic sports injuries -Arthroscopic Surgery (Shoulder/Elbow/Wrist/Hip/Knee/Ankle/Foot) -Relevant translational research -Sports traumatology/epidemiology -Knee and shoulder arthroplasty The OJSM also publishes relevant systematic reviews and meta-analyses. This journal is a member of the Committee on Publication Ethics (COPE).
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信